カテゴリー： 世界, 医療/バイオ, LP Information

世界の蓄膿症治療市場予測 2023年-2029年

【英語タイトル】Global Pyomyositis Treatment Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC02984）・商品コード：LP23DC02984
・発行会社（調査会社）：LP Information
・発行日：2023年11月
・ページ数：115
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の蓄膿症治療市場」は、過去の販売実績から2022年の世界の蓄膿症治療の総販売量を検討し、2023年から2029年の予測される蓄膿症治療の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の蓄膿症治療の市場規模を掲載し、XXX百万米ドル規模の世界の蓄膿症治療市場の詳細な分析を提供します。本インサイトレポートは、世界の蓄膿症治療業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の蓄膿症治療市場における各社の独自のポジションをより深く理解するために、蓄膿症治療製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の蓄膿症治療市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。蓄膿症治療の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。蓄膿症治療の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。蓄膿症治療のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

蓄膿症治療の世界主要メーカーとしては、Novartis AG、 Merck & Co.、 Mallinckrodt、 Akorn、 Amgen Inc、 Bausch Health、 Pfizer Inc.、 Corbus Pharmaceuticals Holdings Inc.、 IDERA、 Genentech、 Inc. AbbVie Inc.、 GlaxoSmithKline plc.、 Milo Biotechnology、 CytRx Corporation、 Sanofi Promega、 AstraZenecaなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の蓄膿症治療市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では蓄膿症治療市場をセグメンテーションし、種類別 (経口式、非経口式)、用途別 (病院薬局、小売薬局、オンライン薬局)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：経口式、非経口式

・用途別区分：病院薬局、小売薬局、オンライン薬局

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の蓄膿症治療市場の10年間の市場状況・展望は？
・世界および地域別に見た蓄膿症治療市場成長の要因は何か？
・蓄膿症治療の市場機会はエンドマーケットの規模によってどのように変化するのか？
・蓄膿症治療のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：蓄膿症治療の年間販売量2018-2029、地域別現状・将来分析
・蓄膿症治療の種類別セグメント：経口式、非経口式
・蓄膿症治療の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・蓄膿症治療の用途別セグメント：病院薬局、小売薬局、オンライン薬局
・蓄膿症治療の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の蓄膿症治療市場
・企業別のグローバル蓄膿症治療市場データ：2018-2023年の年間販売量、市場シェア
・企業別の蓄膿症治療の年間売上：2018-2023年の売上、市場シェア
・企業別の蓄膿症治療販売価格
・主要企業の蓄膿症治療生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

蓄膿症治療の地域別レビュー
・地域別の蓄膿症治療市場規模2018-2023：年間販売量、売上
・主要国別の蓄膿症治療市場規模2018-2023：年間販売量、売上
・南北アメリカの蓄膿症治療販売の成長
・アジア太平洋の蓄膿症治療販売の成長
・ヨーロッパの蓄膿症治療販売の成長
・中東・アフリカの蓄膿症治療販売の成長

南北アメリカ市場
・南北アメリカの国別の蓄膿症治療販売量、売上（2018-2023）
・南北アメリカの蓄膿症治療の種類別販売量
・南北アメリカの蓄膿症治療の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の蓄膿症治療販売量、売上（2018-2023）
・アジア太平洋の蓄膿症治療の種類別販売量
・アジア太平洋の蓄膿症治療の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の蓄膿症治療販売量、売上（2018-2023）
・ヨーロッパの蓄膿症治療の種類別販売量
・ヨーロッパの蓄膿症治療の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の蓄膿症治療販売量、売上（2018-2023）
・中東・アフリカの蓄膿症治療の種類別販売量
・中東・アフリカの蓄膿症治療の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・蓄膿症治療の製造コスト構造分析
・蓄膿症治療の製造プロセス分析
・蓄膿症治療の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・蓄膿症治療の主要なグローバル販売業者
・蓄膿症治療の主要なグローバル顧客

地域別の蓄膿症治療市場予測レビュー
・地域別の蓄膿症治療市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・蓄膿症治療の種類別市場規模予測
・蓄膿症治療の用途別市場規模予測

主要企業分析
Novartis AG、 Merck & Co.、 Mallinckrodt、 Akorn、 Amgen Inc、 Bausch Health、 Pfizer Inc.、 Corbus Pharmaceuticals Holdings Inc.、 IDERA、 Genentech、 Inc. AbbVie Inc.、 GlaxoSmithKline plc.、 Milo Biotechnology、 CytRx Corporation、 Sanofi Promega、 AstraZeneca
・企業情報
・蓄膿症治療製品
・蓄膿症治療販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Pyomyositis Treatment market size is projected to grow from US$ 23280 million in 2022 to US$ 33170 million in 2029; it is expected to grow at a CAGR of 5.2% from 2023 to 2029.
United States market for Pyomyositis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pyomyositis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pyomyositis Treatment is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pyomyositis Treatment players cover Novartis AG, Merck & Co., Mallinckrodt, Akorn, Amgen Inc, Bausch Health, Pfizer Inc., Corbus Pharmaceuticals Holdings Inc. and IDERA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Pyomyositis is a rare bacterial infection of the muscle that usually results in an abscess. It’s most common in your thigh muscles. Pyomyositis can be difficult to diagnose, and symptoms usually include fever and muscle pain. Healthcare providers often treat it with antibiotics.
LPI (LP Information)’ newest research report, the “Pyomyositis Treatment Industry Forecast” looks at past sales and reviews total world Pyomyositis Treatment sales in 2022, providing a comprehensive analysis by region and market sector of projected Pyomyositis Treatment sales for 2023 through 2029. With Pyomyositis Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pyomyositis Treatment industry.
This Insight Report provides a comprehensive analysis of the global Pyomyositis Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pyomyositis Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pyomyositis Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pyomyositis Treatment and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pyomyositis Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Pyomyositis Treatment market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Oral
Parenteral
Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Novartis AG
Merck & Co.
Mallinckrodt
Akorn
Amgen Inc
Bausch Health
Pfizer Inc.
Corbus Pharmaceuticals Holdings Inc.
IDERA
Genentech
Inc. AbbVie Inc.
GlaxoSmithKline plc.
Milo Biotechnology
CytRx Corporation
Sanofi Promega
AstraZeneca
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pyomyositis Treatment market?
What factors are driving Pyomyositis Treatment market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pyomyositis Treatment market opportunities vary by end market size?
How does Pyomyositis Treatment break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pyomyositis Treatment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pyomyositis Treatment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pyomyositis Treatment by Country/Region, 2018, 2022 & 2029
2.2 Pyomyositis Treatment Segment by Type
2.2.1 Oral
2.2.2 Parenteral
2.3 Pyomyositis Treatment Sales by Type
2.3.1 Global Pyomyositis Treatment Sales Market Share by Type (2018-2023)
2.3.2 Global Pyomyositis Treatment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pyomyositis Treatment Sale Price by Type (2018-2023)
2.4 Pyomyositis Treatment Segment by Application
2.4.1 Hospital Pharmacies
2.4.2 Retail Pharmacies
2.4.3 Online Pharmacies
2.5 Pyomyositis Treatment Sales by Application
2.5.1 Global Pyomyositis Treatment Sale Market Share by Application (2018-2023)
2.5.2 Global Pyomyositis Treatment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pyomyositis Treatment Sale Price by Application (2018-2023)
3 Global Pyomyositis Treatment by Company
3.1 Global Pyomyositis Treatment Breakdown Data by Company
3.1.1 Global Pyomyositis Treatment Annual Sales by Company (2018-2023)
3.1.2 Global Pyomyositis Treatment Sales Market Share by Company (2018-2023)
3.2 Global Pyomyositis Treatment Annual Revenue by Company (2018-2023)
3.2.1 Global Pyomyositis Treatment Revenue by Company (2018-2023)
3.2.2 Global Pyomyositis Treatment Revenue Market Share by Company (2018-2023)
3.3 Global Pyomyositis Treatment Sale Price by Company
3.4 Key Manufacturers Pyomyositis Treatment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pyomyositis Treatment Product Location Distribution
3.4.2 Players Pyomyositis Treatment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pyomyositis Treatment by Geographic Region
4.1 World Historic Pyomyositis Treatment Market Size by Geographic Region (2018-2023)
4.1.1 Global Pyomyositis Treatment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pyomyositis Treatment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pyomyositis Treatment Market Size by Country/Region (2018-2023)
4.2.1 Global Pyomyositis Treatment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pyomyositis Treatment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pyomyositis Treatment Sales Growth
4.4 APAC Pyomyositis Treatment Sales Growth
4.5 Europe Pyomyositis Treatment Sales Growth
4.6 Middle East & Africa Pyomyositis Treatment Sales Growth
5 Americas
5.1 Americas Pyomyositis Treatment Sales by Country
5.1.1 Americas Pyomyositis Treatment Sales by Country (2018-2023)
5.1.2 Americas Pyomyositis Treatment Revenue by Country (2018-2023)
5.2 Americas Pyomyositis Treatment Sales by Type
5.3 Americas Pyomyositis Treatment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pyomyositis Treatment Sales by Region
6.1.1 APAC Pyomyositis Treatment Sales by Region (2018-2023)
6.1.2 APAC Pyomyositis Treatment Revenue by Region (2018-2023)
6.2 APAC Pyomyositis Treatment Sales by Type
6.3 APAC Pyomyositis Treatment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pyomyositis Treatment by Country
7.1.1 Europe Pyomyositis Treatment Sales by Country (2018-2023)
7.1.2 Europe Pyomyositis Treatment Revenue by Country (2018-2023)
7.2 Europe Pyomyositis Treatment Sales by Type
7.3 Europe Pyomyositis Treatment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pyomyositis Treatment by Country
8.1.1 Middle East & Africa Pyomyositis Treatment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pyomyositis Treatment Revenue by Country (2018-2023)
8.2 Middle East & Africa Pyomyositis Treatment Sales by Type
8.3 Middle East & Africa Pyomyositis Treatment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pyomyositis Treatment
10.3 Manufacturing Process Analysis of Pyomyositis Treatment
10.4 Industry Chain Structure of Pyomyositis Treatment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pyomyositis Treatment Distributors
11.3 Pyomyositis Treatment Customer
12 World Forecast Review for Pyomyositis Treatment by Geographic Region
12.1 Global Pyomyositis Treatment Market Size Forecast by Region
12.1.1 Global Pyomyositis Treatment Forecast by Region (2024-2029)
12.1.2 Global Pyomyositis Treatment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pyomyositis Treatment Forecast by Type
12.7 Global Pyomyositis Treatment Forecast by Application
13 Key Players Analysis
13.1 Novartis AG
13.1.1 Novartis AG Company Information
13.1.2 Novartis AG Pyomyositis Treatment Product Portfolios and Specifications
13.1.3 Novartis AG Pyomyositis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis AG Main Business Overview
13.1.5 Novartis AG Latest Developments
13.2 Merck & Co.
13.2.1 Merck & Co. Company Information
13.2.2 Merck & Co. Pyomyositis Treatment Product Portfolios and Specifications
13.2.3 Merck & Co. Pyomyositis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Merck & Co. Main Business Overview
13.2.5 Merck & Co. Latest Developments
13.3 Mallinckrodt
13.3.1 Mallinckrodt Company Information
13.3.2 Mallinckrodt Pyomyositis Treatment Product Portfolios and Specifications
13.3.3 Mallinckrodt Pyomyositis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Mallinckrodt Main Business Overview
13.3.5 Mallinckrodt Latest Developments
13.4 Akorn
13.4.1 Akorn Company Information
13.4.2 Akorn Pyomyositis Treatment Product Portfolios and Specifications
13.4.3 Akorn Pyomyositis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Akorn Main Business Overview
13.4.5 Akorn Latest Developments
13.5 Amgen Inc
13.5.1 Amgen Inc Company Information
13.5.2 Amgen Inc Pyomyositis Treatment Product Portfolios and Specifications
13.5.3 Amgen Inc Pyomyositis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Amgen Inc Main Business Overview
13.5.5 Amgen Inc Latest Developments
13.6 Bausch Health
13.6.1 Bausch Health Company Information
13.6.2 Bausch Health Pyomyositis Treatment Product Portfolios and Specifications
13.6.3 Bausch Health Pyomyositis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Bausch Health Main Business Overview
13.6.5 Bausch Health Latest Developments
13.7 Pfizer Inc.
13.7.1 Pfizer Inc. Company Information
13.7.2 Pfizer Inc. Pyomyositis Treatment Product Portfolios and Specifications
13.7.3 Pfizer Inc. Pyomyositis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Pfizer Inc. Main Business Overview
13.7.5 Pfizer Inc. Latest Developments
13.8 Corbus Pharmaceuticals Holdings Inc.
13.8.1 Corbus Pharmaceuticals Holdings Inc. Company Information
13.8.2 Corbus Pharmaceuticals Holdings Inc. Pyomyositis Treatment Product Portfolios and Specifications
13.8.3 Corbus Pharmaceuticals Holdings Inc. Pyomyositis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Corbus Pharmaceuticals Holdings Inc. Main Business Overview
13.8.5 Corbus Pharmaceuticals Holdings Inc. Latest Developments
13.9 IDERA
13.9.1 IDERA Company Information
13.9.2 IDERA Pyomyositis Treatment Product Portfolios and Specifications
13.9.3 IDERA Pyomyositis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 IDERA Main Business Overview
13.9.5 IDERA Latest Developments
13.10 Genentech
13.10.1 Genentech Company Information
13.10.2 Genentech Pyomyositis Treatment Product Portfolios and Specifications
13.10.3 Genentech Pyomyositis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Genentech Main Business Overview
13.10.5 Genentech Latest Developments
13.11 Inc. AbbVie Inc.
13.11.1 Inc. AbbVie Inc. Company Information
13.11.2 Inc. AbbVie Inc. Pyomyositis Treatment Product Portfolios and Specifications
13.11.3 Inc. AbbVie Inc. Pyomyositis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Inc. AbbVie Inc. Main Business Overview
13.11.5 Inc. AbbVie Inc. Latest Developments
13.12 GlaxoSmithKline plc.
13.12.1 GlaxoSmithKline plc. Company Information
13.12.2 GlaxoSmithKline plc. Pyomyositis Treatment Product Portfolios and Specifications
13.12.3 GlaxoSmithKline plc. Pyomyositis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 GlaxoSmithKline plc. Main Business Overview
13.12.5 GlaxoSmithKline plc. Latest Developments
13.13 Milo Biotechnology
13.13.1 Milo Biotechnology Company Information
13.13.2 Milo Biotechnology Pyomyositis Treatment Product Portfolios and Specifications
13.13.3 Milo Biotechnology Pyomyositis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Milo Biotechnology Main Business Overview
13.13.5 Milo Biotechnology Latest Developments
13.14 CytRx Corporation
13.14.1 CytRx Corporation Company Information
13.14.2 CytRx Corporation Pyomyositis Treatment Product Portfolios and Specifications
13.14.3 CytRx Corporation Pyomyositis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 CytRx Corporation Main Business Overview
13.14.5 CytRx Corporation Latest Developments
13.15 Sanofi Promega
13.15.1 Sanofi Promega Company Information
13.15.2 Sanofi Promega Pyomyositis Treatment Product Portfolios and Specifications
13.15.3 Sanofi Promega Pyomyositis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Sanofi Promega Main Business Overview
13.15.5 Sanofi Promega Latest Developments
13.16 AstraZeneca
13.16.1 AstraZeneca Company Information
13.16.2 AstraZeneca Pyomyositis Treatment Product Portfolios and Specifications
13.16.3 AstraZeneca Pyomyositis Treatment Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 AstraZeneca Main Business Overview
13.16.5 AstraZeneca Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Pyomyositis Treatment Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pyomyositis Treatment Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Oral
Table 4. Major Players of Parenteral
Table 5. Global Pyomyositis Treatment Sales by Type (2018-2023) & (K Units)
Table 6. Global Pyomyositis Treatment Sales Market Share by Type (2018-2023)
Table 7. Global Pyomyositis Treatment Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pyomyositis Treatment Revenue Market Share by Type (2018-2023)
Table 9. Global Pyomyositis Treatment Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Pyomyositis Treatment Sales by Application (2018-2023) & (K Units)
Table 11. Global Pyomyositis Treatment Sales Market Share by Application (2018-2023)
Table 12. Global Pyomyositis Treatment Revenue by Application (2018-2023)
Table 13. Global Pyomyositis Treatment Revenue Market Share by Application (2018-2023)
Table 14. Global Pyomyositis Treatment Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Pyomyositis Treatment Sales by Company (2018-2023) & (K Units)
Table 16. Global Pyomyositis Treatment Sales Market Share by Company (2018-2023)
Table 17. Global Pyomyositis Treatment Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pyomyositis Treatment Revenue Market Share by Company (2018-2023)
Table 19. Global Pyomyositis Treatment Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Pyomyositis Treatment Producing Area Distribution and Sales Area
Table 21. Players Pyomyositis Treatment Products Offered
Table 22. Pyomyositis Treatment Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pyomyositis Treatment Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Pyomyositis Treatment Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pyomyositis Treatment Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pyomyositis Treatment Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pyomyositis Treatment Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Pyomyositis Treatment Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pyomyositis Treatment Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pyomyositis Treatment Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pyomyositis Treatment Sales by Country (2018-2023) & (K Units)
Table 34. Americas Pyomyositis Treatment Sales Market Share by Country (2018-2023)
Table 35. Americas Pyomyositis Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pyomyositis Treatment Revenue Market Share by Country (2018-2023)
Table 37. Americas Pyomyositis Treatment Sales by Type (2018-2023) & (K Units)
Table 38. Americas Pyomyositis Treatment Sales by Application (2018-2023) & (K Units)
Table 39. APAC Pyomyositis Treatment Sales by Region (2018-2023) & (K Units)
Table 40. APAC Pyomyositis Treatment Sales Market Share by Region (2018-2023)
Table 41. APAC Pyomyositis Treatment Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pyomyositis Treatment Revenue Market Share by Region (2018-2023)
Table 43. APAC Pyomyositis Treatment Sales by Type (2018-2023) & (K Units)
Table 44. APAC Pyomyositis Treatment Sales by Application (2018-2023) & (K Units)
Table 45. Europe Pyomyositis Treatment Sales by Country (2018-2023) & (K Units)
Table 46. Europe Pyomyositis Treatment Sales Market Share by Country (2018-2023)
Table 47. Europe Pyomyositis Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pyomyositis Treatment Revenue Market Share by Country (2018-2023)
Table 49. Europe Pyomyositis Treatment Sales by Type (2018-2023) & (K Units)
Table 50. Europe Pyomyositis Treatment Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Pyomyositis Treatment Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Pyomyositis Treatment Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pyomyositis Treatment Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pyomyositis Treatment Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pyomyositis Treatment Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Pyomyositis Treatment Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Pyomyositis Treatment
Table 58. Key Market Challenges & Risks of Pyomyositis Treatment
Table 59. Key Industry Trends of Pyomyositis Treatment
Table 60. Pyomyositis Treatment Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pyomyositis Treatment Distributors List
Table 63. Pyomyositis Treatment Customer List
Table 64. Global Pyomyositis Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Pyomyositis Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pyomyositis Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Pyomyositis Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pyomyositis Treatment Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Pyomyositis Treatment Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pyomyositis Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Pyomyositis Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pyomyositis Treatment Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Pyomyositis Treatment Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pyomyositis Treatment Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Pyomyositis Treatment Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pyomyositis Treatment Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Pyomyositis Treatment Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Novartis AG Basic Information, Pyomyositis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 79. Novartis AG Pyomyositis Treatment Product Portfolios and Specifications
Table 80. Novartis AG Pyomyositis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Novartis AG Main Business
Table 82. Novartis AG Latest Developments
Table 83. Merck & Co. Basic Information, Pyomyositis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck & Co. Pyomyositis Treatment Product Portfolios and Specifications
Table 85. Merck & Co. Pyomyositis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Merck & Co. Main Business
Table 87. Merck & Co. Latest Developments
Table 88. Mallinckrodt Basic Information, Pyomyositis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 89. Mallinckrodt Pyomyositis Treatment Product Portfolios and Specifications
Table 90. Mallinckrodt Pyomyositis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Mallinckrodt Main Business
Table 92. Mallinckrodt Latest Developments
Table 93. Akorn Basic Information, Pyomyositis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 94. Akorn Pyomyositis Treatment Product Portfolios and Specifications
Table 95. Akorn Pyomyositis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Akorn Main Business
Table 97. Akorn Latest Developments
Table 98. Amgen Inc Basic Information, Pyomyositis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 99. Amgen Inc Pyomyositis Treatment Product Portfolios and Specifications
Table 100. Amgen Inc Pyomyositis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. Amgen Inc Main Business
Table 102. Amgen Inc Latest Developments
Table 103. Bausch Health Basic Information, Pyomyositis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 104. Bausch Health Pyomyositis Treatment Product Portfolios and Specifications
Table 105. Bausch Health Pyomyositis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Bausch Health Main Business
Table 107. Bausch Health Latest Developments
Table 108. Pfizer Inc. Basic Information, Pyomyositis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 109. Pfizer Inc. Pyomyositis Treatment Product Portfolios and Specifications
Table 110. Pfizer Inc. Pyomyositis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Pfizer Inc. Main Business
Table 112. Pfizer Inc. Latest Developments
Table 113. Corbus Pharmaceuticals Holdings Inc. Basic Information, Pyomyositis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 114. Corbus Pharmaceuticals Holdings Inc. Pyomyositis Treatment Product Portfolios and Specifications
Table 115. Corbus Pharmaceuticals Holdings Inc. Pyomyositis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Corbus Pharmaceuticals Holdings Inc. Main Business
Table 117. Corbus Pharmaceuticals Holdings Inc. Latest Developments
Table 118. IDERA Basic Information, Pyomyositis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 119. IDERA Pyomyositis Treatment Product Portfolios and Specifications
Table 120. IDERA Pyomyositis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. IDERA Main Business
Table 122. IDERA Latest Developments
Table 123. Genentech Basic Information, Pyomyositis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 124. Genentech Pyomyositis Treatment Product Portfolios and Specifications
Table 125. Genentech Pyomyositis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Genentech Main Business
Table 127. Genentech Latest Developments
Table 128. Inc. AbbVie Inc. Basic Information, Pyomyositis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 129. Inc. AbbVie Inc. Pyomyositis Treatment Product Portfolios and Specifications
Table 130. Inc. AbbVie Inc. Pyomyositis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 131. Inc. AbbVie Inc. Main Business
Table 132. Inc. AbbVie Inc. Latest Developments
Table 133. GlaxoSmithKline plc. Basic Information, Pyomyositis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 134. GlaxoSmithKline plc. Pyomyositis Treatment Product Portfolios and Specifications
Table 135. GlaxoSmithKline plc. Pyomyositis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 136. GlaxoSmithKline plc. Main Business
Table 137. GlaxoSmithKline plc. Latest Developments
Table 138. Milo Biotechnology Basic Information, Pyomyositis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 139. Milo Biotechnology Pyomyositis Treatment Product Portfolios and Specifications
Table 140. Milo Biotechnology Pyomyositis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 141. Milo Biotechnology Main Business
Table 142. Milo Biotechnology Latest Developments
Table 143. CytRx Corporation Basic Information, Pyomyositis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 144. CytRx Corporation Pyomyositis Treatment Product Portfolios and Specifications
Table 145. CytRx Corporation Pyomyositis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 146. CytRx Corporation Main Business
Table 147. CytRx Corporation Latest Developments
Table 148. Sanofi Promega Basic Information, Pyomyositis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 149. Sanofi Promega Pyomyositis Treatment Product Portfolios and Specifications
Table 150. Sanofi Promega Pyomyositis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 151. Sanofi Promega Main Business
Table 152. Sanofi Promega Latest Developments
Table 153. AstraZeneca Basic Information, Pyomyositis Treatment Manufacturing Base, Sales Area and Its Competitors
Table 154. AstraZeneca Pyomyositis Treatment Product Portfolios and Specifications
Table 155. AstraZeneca Pyomyositis Treatment Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 156. AstraZeneca Main Business
Table 157. AstraZeneca Latest Developments
List of Figures
Figure 1. Picture of Pyomyositis Treatment
Figure 2. Pyomyositis Treatment Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pyomyositis Treatment Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Pyomyositis Treatment Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pyomyositis Treatment Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Oral
Figure 10. Product Picture of Parenteral
Figure 11. Global Pyomyositis Treatment Sales Market Share by Type in 2022
Figure 12. Global Pyomyositis Treatment Revenue Market Share by Type (2018-2023)
Figure 13. Pyomyositis Treatment Consumed in Hospital Pharmacies
Figure 14. Global Pyomyositis Treatment Market: Hospital Pharmacies (2018-2023) & (K Units)
Figure 15. Pyomyositis Treatment Consumed in Retail Pharmacies
Figure 16. Global Pyomyositis Treatment Market: Retail Pharmacies (2018-2023) & (K Units)
Figure 17. Pyomyositis Treatment Consumed in Online Pharmacies
Figure 18. Global Pyomyositis Treatment Market: Online Pharmacies (2018-2023) & (K Units)
Figure 19. Global Pyomyositis Treatment Sales Market Share by Application (2022)
Figure 20. Global Pyomyositis Treatment Revenue Market Share by Application in 2022
Figure 21. Pyomyositis Treatment Sales Market by Company in 2022 (K Units)
Figure 22. Global Pyomyositis Treatment Sales Market Share by Company in 2022
Figure 23. Pyomyositis Treatment Revenue Market by Company in 2022 ($ Million)
Figure 24. Global Pyomyositis Treatment Revenue Market Share by Company in 2022
Figure 25. Global Pyomyositis Treatment Sales Market Share by Geographic Region (2018-2023)
Figure 26. Global Pyomyositis Treatment Revenue Market Share by Geographic Region in 2022
Figure 27. Americas Pyomyositis Treatment Sales 2018-2023 (K Units)
Figure 28. Americas Pyomyositis Treatment Revenue 2018-2023 ($ Millions)
Figure 29. APAC Pyomyositis Treatment Sales 2018-2023 (K Units)
Figure 30. APAC Pyomyositis Treatment Revenue 2018-2023 ($ Millions)
Figure 31. Europe Pyomyositis Treatment Sales 2018-2023 (K Units)
Figure 32. Europe Pyomyositis Treatment Revenue 2018-2023 ($ Millions)
Figure 33. Middle East & Africa Pyomyositis Treatment Sales 2018-2023 (K Units)
Figure 34. Middle East & Africa Pyomyositis Treatment Revenue 2018-2023 ($ Millions)
Figure 35. Americas Pyomyositis Treatment Sales Market Share by Country in 2022
Figure 36. Americas Pyomyositis Treatment Revenue Market Share by Country in 2022
Figure 37. Americas Pyomyositis Treatment Sales Market Share by Type (2018-2023)
Figure 38. Americas Pyomyositis Treatment Sales Market Share by Application (2018-2023)
Figure 39. United States Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 40. Canada Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 41. Mexico Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 42. Brazil Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 43. APAC Pyomyositis Treatment Sales Market Share by Region in 2022
Figure 44. APAC Pyomyositis Treatment Revenue Market Share by Regions in 2022
Figure 45. APAC Pyomyositis Treatment Sales Market Share by Type (2018-2023)
Figure 46. APAC Pyomyositis Treatment Sales Market Share by Application (2018-2023)
Figure 47. China Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 48. Japan Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 49. South Korea Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 50. Southeast Asia Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 51. India Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 52. Australia Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 53. China Taiwan Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 54. Europe Pyomyositis Treatment Sales Market Share by Country in 2022
Figure 55. Europe Pyomyositis Treatment Revenue Market Share by Country in 2022
Figure 56. Europe Pyomyositis Treatment Sales Market Share by Type (2018-2023)
Figure 57. Europe Pyomyositis Treatment Sales Market Share by Application (2018-2023)
Figure 58. Germany Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 59. France Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 60. UK Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 61. Italy Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 62. Russia Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 63. Middle East & Africa Pyomyositis Treatment Sales Market Share by Country in 2022
Figure 64. Middle East & Africa Pyomyositis Treatment Revenue Market Share by Country in 2022
Figure 65. Middle East & Africa Pyomyositis Treatment Sales Market Share by Type (2018-2023)
Figure 66. Middle East & Africa Pyomyositis Treatment Sales Market Share by Application (2018-2023)
Figure 67. Egypt Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 68. South Africa Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 69. Israel Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 70. Turkey Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 71. GCC Country Pyomyositis Treatment Revenue Growth 2018-2023 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Pyomyositis Treatment in 2022
Figure 73. Manufacturing Process Analysis of Pyomyositis Treatment
Figure 74. Industry Chain Structure of Pyomyositis Treatment
Figure 75. Channels of Distribution
Figure 76. Global Pyomyositis Treatment Sales Market Forecast by Region (2024-2029)
Figure 77. Global Pyomyositis Treatment Revenue Market Share Forecast by Region (2024-2029)
Figure 78. Global Pyomyositis Treatment Sales Market Share Forecast by Type (2024-2029)
Figure 79. Global Pyomyositis Treatment Revenue Market Share Forecast by Type (2024-2029)
Figure 80. Global Pyomyositis Treatment Sales Market Share Forecast by Application (2024-2029)
Figure 81. Global Pyomyositis Treatment Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の蓄膿症治療市場予測 2023年-2029年] (コード：LP23DC02984)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の蓄膿症治療市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の筋骨格系腫瘍治療市場予測 2023年-2029年
  • 世界の前立腺肥大症治療装置市場予測 2023年-2029年
  • 世界の膜性腎症治療市場予測 2023年-2029年
  • 世界のアルコール使用障害用治療市場予測 2023年-2029年
  • 世界のTEN治療市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆